olanzapine and fluoxetine

Generic: olanzapine and fuoxetine

Labeler: endo usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olanzapine and fluoxetine
Generic Name olanzapine and fuoxetine
Labeler endo usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

fluoxetine hydrochloride 25 mg/1, olanzapine 3 mg/1

Manufacturer
Endo USA, Inc.

Identifiers & Regulatory

Product NDC 49884-277
Product ID 49884-277_c2eef390-8690-4148-ac37-45e392be15a6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077742
Listing Expiration 2026-12-31
Marketing Start 2012-11-26

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49884277
Hyphenated Format 49884-277

Supplemental Identifiers

RxCUI
403969 403970 403971 403972 721787
UPC
0349884253110 0349884277116 0349884250119 0349884251116 0349884252113
UNII
N7U69T4SZR I9W7N6B1KJ
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olanzapine and fluoxetine (source: ndc)
Generic Name olanzapine and fuoxetine (source: ndc)
Application Number ANDA077742 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
  • 3 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (49884-277-11)
source: ndc

Packages (1)

Ingredients (2)

fluoxetine hydrochloride (25 mg/1) olanzapine (3 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c2eef390-8690-4148-ac37-45e392be15a6", "openfda": {"nui": ["N0000175430"], "upc": ["0349884253110", "0349884277116", "0349884250119", "0349884251116", "0349884252113"], "unii": ["N7U69T4SZR", "I9W7N6B1KJ"], "rxcui": ["403969", "403970", "403971", "403972", "721787"], "spl_set_id": ["2f6ceda3-3edc-4427-98a6-23e3c930c44d"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (49884-277-11)", "package_ndc": "49884-277-11", "marketing_start_date": "20121126"}], "brand_name": "Olanzapine and Fluoxetine", "product_id": "49884-277_c2eef390-8690-4148-ac37-45e392be15a6", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]", "Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "49884-277", "generic_name": "olanzapine and fuoxetine", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine and Fluoxetine", "active_ingredients": [{"name": "FLUOXETINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "OLANZAPINE", "strength": "3 mg/1"}], "application_number": "ANDA077742", "marketing_category": "ANDA", "marketing_start_date": "20121126", "listing_expiration_date": "20261231"}